Conclusion
These findings suggest that ATRA can induce severe thrombocytosis, as a
potential side effect of treatment, in APL patients through stimulating
the productions of different cytokines, especially IL-6, from APL cells
under differentiation. However, further studies and more information are
needed to confirm this conclusion and provide criteria for its
management.